US-based hearing aid manufacturer Eargo, which is spearheaded by Danish national Christian Gormsen, is in troubled waters.
The firm is currently at the center of an investigation concerning potential reimbursement fraud, and the New York stock exchange Nasdaq has also threatened to delist the company should it fail to file a missing third quarterly report.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.